Launch of the Call for Projects Innovation Prize 2017

For the 9th consecutive year, Universal Biotech, a consulting company specialized in the innovation management in the healthcare sector, launches its call for the Innovation Prize. This prize awards young start-ups (<8 years old) and academic research groups developing innovative projects in the field of human healthcare. This year, 3 prizes will be awarded:
  • Biotech Awards
  • Medtech Awards
  • Digitech Awards (health NICTs including e/m-health, platforms and connected objects).

Since its launch, this competition has benefited or benefits from the support of numerous healthcare companies like GSK, L'Oréal, Pierre Fabre, Servier and many others, as well as internationally renowned academic institutions such as ANR, European Commission, Pasteur Institute and Karolinska Institutet which contributes to its achievement. The success of the Innovation Prize is demonstrated by the fact that among the 34 startups which have reached the final step of the competition, 60% of them raised fund or performed partnerships with an industrial.

The 8th edition attracted more than 250 candidates from 38 different countries, resulting in the selection of two laureates, BioVersys (Switzerland) and Pathmaker Neurosystems (USA). Each one of these two teams received a prize divided between a financial grant and consulting services provided by Universal Biotech.

For this 9th edition, the call for projects platform, Open Innovation Access, is open from February 1st till April 30th, 2017. Project leaders will be able to apply online by filling an application allowing jury members to evaluate the quality of projects according to the following criteria:

  • Scientific quality of the innovation,
  • Team quality,
  • Intellectual Property strategy,
  • Project feasibility,
  • Chances of success on the market.

After the selection step, Universal Biotech and the jury will reward the three winners at the Innovation Prize Awards Ceremony on October the 3rd, 2017.

The Innovation Prize is an opportunity for you to introduce your innovative project to potential partners and investors. Furthermore, by participating in this competition, you will boost your visibility and also offer you a unique chance to obtain high-quality feedback from experts of the healthcare sector.

For further information, please visit:
https://www.universal-biotech-prize.com

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...